(Q73348058)
Statements
A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome (English)
K D Bardhan
G Bodemar
H Geldof
E Schütz
A Heath
J G Mills